VEGFA anticorps (Isoform 6)
Aperçu rapide pour VEGFA anticorps (Isoform 6) (ABIN6254198)
Antigène
Voir toutes VEGFA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Isoform 6
-
Fonction
- Anti-VEGFA
-
Séquence
- MNFLLSWVHW SLALLLYLHH AKWSQAAPMA EGGGQNHHEV VKFMDVYQRS YCHPIETLVD IFQEYPDEIE YIFKPSCVPL MRCGGCCNDE GLECVPTEES NITMQIMRIK PHQGQHIGEM SFLQHNKCEC RPKKDRARQE KCDKPRR
-
Specificité
- Detects endogenous levels of total VEGFA by Western blot in whole cell and tissue lysates.
-
Attributs du produit
- Vascular endothelial growth factor A
-
Purification
- Epitope affinity purified
-
Immunogène
- Purified recombinant human VEGFA isoform 6 produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:250-1:2,000, IF:1:50-1:250
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- The antibody solution should be gently mixed before use.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
-
: "Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance." dans: Scientific reports, Vol. 7, Issue 1, pp. 1698, (2018) (PubMed).
-
: "Methylglyoxal-induced glycation changes adipose tissue vascular architecture, flow and expansion, leading to insulin resistance." dans: Scientific reports, Vol. 7, Issue 1, pp. 1698, (2018) (PubMed).
-
- VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
-
Autre désignation
- VEGFA
-
Sujet
-
Goat polyclonal to VEGFA. This protein is a member of the PDGF/VEGF growth factor family. It is a glycosylated mitogen that specifically acts on endothelial cells and has various effects such as mediating increased vascular permeability, endothelial cell growth, promoting cell migration, inducing angiogenesis and inhibiting apoptosis.
MVCD1, RP1-261G23.1, VEGF, vascular permeability factor and VPF antibody.
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Antigène
-